Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» chronic lymphocytic leukemia
chronic lymphocytic leukemia
AZ's deal for Acerta already showing promise as cancer drug wins orphan nod
BioPharma Dive
Fri, 02/26/16 - 10:31 pm
AstraZeneca
Acerta
chronic lymphocytic leukemia
acalabrutinib
Roche and AbbVie line up for quick approval for cancer drug venetoclax
Fierce Biotech
Tue, 01/12/16 - 09:19 pm
AbbVie
Roche
venetoclax
chronic lymphocytic leukemia
Will This Study Finally Catapult Gilead Sciences Into a Cancer Powerhouse?
Motley Fool
Thu, 12/10/15 - 10:39 am
Gilead Sciences
Zydelig
CLL
chronic lymphocytic leukemia
Can new PhIII data help Gilead's Zydelig stage a comeback in CLL?
Fierce Pharma Marketing
Wed, 12/9/15 - 11:36 am
Gilead Sciences
Zydelig
chronic lymphocytic leukemia
CLL
Here’s How AbbVie, JNJ May Turn Imbruvica into a $12 Billion Drug
Bidness, ETC
Mon, 12/7/15 - 10:37 am
AbbVie
JNJ
Imbruvica
chronic lymphocytic leukemia
There's a 0.0000000000028% Chance This Drug Doesn't Work
Motley Fool
Tue, 12/1/15 - 10:12 am
Gilead Sciences
Zydelig
chronic lymphocytic leukemia
AbbVie Submits IMBRUVICA® (ibrutinib) Phase III Combination Data to U.S. FDA
Yahoo
Fri, 11/13/15 - 10:59 am
AbbVie
Imbruvica
bendamustine
rituximab
chronic lymphocytic leukemia
FDA
U.K. cost gatekeeper gives thumbs-up to Gilead's Zydelig for CLL
Fierce Pharma
Thu, 09/24/15 - 11:50 am
UK
Gilead Sciences
Zydelig
CLL
chronic lymphocytic leukemia
AbbVie edges closer to Imbruvica deal payoff with another FDA filing
Fierce Pharma
Tue, 09/15/15 - 03:16 pm
AbbVie
Imbruvica
FDA
JNJ
CLL
chronic lymphocytic leukemia
Novartis team tracks remissions of 4-plus years in a pioneering CAR-T study
Fierce Biotech
Thu, 09/3/15 - 08:40 am
Novartis
CAR-T
CTL019
CLL
chronic lymphocytic leukemia
AbbVie Inc May Use Priority Voucher To Gain Lymphoma Lead Over Roche
Bidness, ETC
Thu, 08/20/15 - 11:53 am
AbbVie
priority review
Roche
CLL
chronic lymphocytic leukemia
United Therapeutics
AbbVie to seek FDA approval for leukemia drug after trial success
Yahoo/Reuters
Wed, 08/12/15 - 10:35 am
AbbVie
FDA
Roche
chronic lymphocytic leukemia
CLL
venetoclax
Novartis files leukemia drug Arzerra in the EU
BioPharma Dive
Thu, 07/9/15 - 07:42 pm
Novartis
Arzerra
Europe
Genmab
CLL
chronic lymphocytic leukemia
GSK deal keeps paying off for Novartis with more positive Arzerra data
Fierce Pharma
Fri, 06/12/15 - 10:53 pm
GSK
Novartis
Arzerra
chronic lymphocytic leukemia
Infinity Reports Phase 1 Data Showing Clinical Activity of Duvelisib in Treatment-Naïve Patients with Chronic Lymphocytic Leukemia
Yahoo
Sun, 05/31/15 - 11:30 am
Infinity Pharmaceuticals
ASCO
duvelisib
chronic lymphocytic leukemia
CLL
AbbVie, Roche nab FDA breakthrough designation for top leukemia prospect
BioPharma Dive
Fri, 05/8/15 - 11:01 am
AbbVie
Roche
FDA
CLL
chronic lymphocytic leukemia
venetoclax
AbbVie leukemia drug gets breakthrough status
Medical Marketing and Media
Wed, 05/6/15 - 06:59 pm
AbbVie
CLL
chronic lymphocytic leukemia
venetoclax
Novartis has fresh data to support newly acquired CCL drug Arzerra
Fierce Pharma
Wed, 04/15/15 - 10:30 am
Novartis
Arzerra
chronic lymphocytic leukemia
GSK
J&J-Pharmacyclics drug shows potential in high-risk leukemia patients
Yahoo/Reuters
Tue, 02/17/15 - 12:46 pm
JNJ
Pharmacyclics
Imbruvica
chronic lymphocytic leukemia
Imbruvica performs well in high-risk leukemia patients
Seeking Alpha
Mon, 01/5/15 - 04:10 pm
Imbruvica
CLL
chronic lymphocytic leukemia
Pharmacyclics
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »